Skip to content

Drug interactions

Elagolix + Temsirolimus

Severity: Moderate

Elagolix and Temsirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix is a P-glycoprotein inhibitor and a weak-to-moderate CYP3A4 inducer, so effects on temsirolimus exposure may go in either direction. The net clinical effect is unpredictable.

What this interaction means in plain words

Elagolix and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Elagolix belongs to Musculoskeletal; Temsirolimus belongs to Oncology.

Evidence level: Low

Why it happens

Combined P-glycoprotein inhibition and CYP3A4 induction by elagolix.

What to do

Monitor for temsirolimus toxicity and for reduced efficacy. Adjust dosing according to clinical response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Temsirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Temsirolimus?

MediHelp rates the interaction as moderate. Elagolix and Temsirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Elagolix is a P-glycoprotein inhibitor and a weak-to-moderate CYP3A4 inducer, so effects on temsirolimus exposure may go in either direction. The net clinical effect is unpredictable.

How serious is the interaction between Elagolix and Temsirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for temsirolimus toxicity and for reduced efficacy. Adjust dosing according to clinical response.

What other medicines interact with Temsirolimus?

MediHelp also lists interactions of Temsirolimus with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine live. The full list is on the Temsirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in